These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 18853664

  • 21. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
    Agarwal R.
    Am J Physiol Renal Physiol; 2003 Apr; 284(4):F863-9. PubMed ID: 12505865
    [Abstract] [Full Text] [Related]

  • 22. Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury?
    Ryan MJ, Tuttle KR.
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):443-9. PubMed ID: 18695383
    [Abstract] [Full Text] [Related]

  • 23. Long-term effects of losartan on proteinuria and renal function in patients with renal amyloidosis.
    Dilek K, Usta M, Ersoy A, Ozdemir B, Yavuz M, Güllülü M, Yurtkuran M.
    Scand J Urol Nephrol; 2002 Sep; 36(6):443-6. PubMed ID: 12623509
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P, Felgueiras J, Santos C, Oliveira C, Ponce P.
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [Abstract] [Full Text] [Related]

  • 25. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
    Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ.
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214
    [Abstract] [Full Text] [Related]

  • 26. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 27. Dual renin-angiotensin system blockade: in patients with single functioning kidney and proteinuria.
    Robles NR, Ruiz Jiménez B, Hernández Gallego R, Ruiz-Calero R, Sánchez Casado E, Cubero JJ.
    Eur J Intern Med; 2009 Mar; 20(2):186-9. PubMed ID: 19327610
    [Abstract] [Full Text] [Related]

  • 28. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [Abstract] [Full Text] [Related]

  • 29. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 30. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 31. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA, Khosla N, Bakris GL.
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [Abstract] [Full Text] [Related]

  • 32. Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Bakris GL, Weir MR.
    Postgrad Med; 2008 Apr; 120(1):33-42. PubMed ID: 18467807
    [Abstract] [Full Text] [Related]

  • 33. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
    Ghorbani A, Omidvar B, Beladi-Mousavi SS, Lak E, Vaziri S.
    Nefrologia; 2012 Apr; 32(6):790-6. PubMed ID: 23169362
    [Abstract] [Full Text] [Related]

  • 34. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 35. Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria.
    Lubrano R, Soscia F, Elli M, Ventriglia F, Raggi C, Travasso E, Scateni S, Di Maio V, Versacci P, Masciangelo R, Romero S.
    Pediatrics; 2006 Sep; 118(3):e833-8. PubMed ID: 16923922
    [Abstract] [Full Text] [Related]

  • 36. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP.
    J Am Soc Nephrol; 2007 Jun; 18(6):1889-98. PubMed ID: 17494885
    [Abstract] [Full Text] [Related]

  • 37. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Jun; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 38. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
    Robles NR, Cancho B, Barroso S, Martín MV, Sánchez Casado E.
    Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
    [Abstract] [Full Text] [Related]

  • 39. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J, Vítovec J, Soucek M, Dusek L, Pavlík T, CORD Invesigators.
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [Abstract] [Full Text] [Related]

  • 40. Effects of ramipril and valsartan on proteinuria and renal function in patients with nondiabetic proteinuria.
    Bilić M, Munjas-Samarin R, Ljubanović D, Horvatić I, Galesić K.
    Coll Antropol; 2011 Dec; 35(4):1061-6. PubMed ID: 22397239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.